Renalase, kidney function, and markers of endothelial dysfunction in renal transplant recipients

Polskie Archiwum Medycyny Wewnetrznej

Volumn 122, Issue 1-2, 2012, Pages 40-44

  Zbroch, Edyta ^a   Małyszko, Jolanta ^a   Małyszko, Jacek ^a   Koc Zorawska, Ewa ^a   Myśliwiec, Michalł ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Blood pressure; Kidney function; Kidney transplantation; Renalase

Indexed keywords

ANTIPLASMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CD146 ANTIGEN; CELL ADHESION MOLECULE; CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HERMES ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE; INTERLEUKIN 6; KIDNEY ENZYME; LIPID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHATE; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR; PREDNISONE; RENALASE; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UREA; VASCULAR CELL ADHESION MOLECULE; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM INJURY; ENZYME BLOOD LEVEL; FEMALE; FIBRINOLYSIS; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL;

EID: 84857579716     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1132     Document Type: Article

References (20)

1. Mancuso P, Antoniotti P, Quarna J, et al. Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses. Clin Cancer Res. 2009; 15: 267-273.
2. Wa̧torek E, Paprocka M, Duś D, et al. Endostatin and vascular endothelial growth factor: potential regulators of endothelial progenitor cell number in chronic kidney disease. Pol Arch Med Wewn. 2011; 121: 296-301.
3. Hogas S, Ardeleanu S, Segall L, et al. Changes in arterial stiffness following dialysis in relation to overhydration and to endothelial function. Int Urol Nephrol. 2011. [Epub ahead of print].
4. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation. 2004; 110: 32-35. (Pubitemid 38880131)
5. Mallamaci F, Tripepi G, Cutrupi S, et al. Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int. 2005; 67: 2330-2337. (Pubitemid 41623394)
6. Xu J, Li G, Wang P, et al. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest. 2005; 115: 1275-1280. (Pubitemid 40629046)
7. Hennebry SC, Eikelis N, Socratous F, et al. Renalase, a novel soluble FAD-dependent protein, is synthesized in the brain and peripheral nerves. Mol Psychiatry. 2010; 15: 234-236.
8. Li G, Xu J, Wang P, et al. Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation. 2008; 117: 1277-1282. (Pubitemid 351365660)
9. Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M. The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipients. Transplantation. 1996; 62: 828-830. (Pubitemid 26332849)
10. Levey AS, Berg RL, Gassman JJ, et al. Creatinine filtration, secretion and excretion during progressive renal disease. Modification of diet in Renal Disease Study Group. Kidney Int. 1989; 36: S73-80.
11. Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150: 604-612.
12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31-41.
13. Malyszko J, Malyszko JS, Mysliwiec M. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients. Clin Transplant. 2009; 68: 681-686.
14. Gross P, Schirutschke H, Barnett K. Should we prescribe blood pressure lowering drugs to every patient with advanced chronic kidney disease? A comment on two recent meta-analyses. Pol Arch Med Wewn. 2009; 119: 644-647.
15. Pecoits-Filho R, Heimbürger O, Bárány P, et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis. 2003; 41: 1212-1218. (Pubitemid 36637976)
16. Schlaich M, Socratous F, Eikelis N, et al. Renalase plasma levels are associated with systolic blood pressure in patients with resistant hypertension. J Hypertens. 2010; 28: e437.
17. Zhao Q, Fan Z, He J, et al. Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population. J Mol Med. 2007; 85: 877-885. (Pubitemid 47077106)
18. Farzaneh-Far R, Desir GV, Na B, et al. A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study. PLoS One. 2010; 5: e13 496.
19. Stec A, Semczuk A, Furmaga J, et al. Polymorphism of the renalase gene in end-stage renal disease patients affected by hypertension. Nephrol Dial Transplant. 2011. [Epub ahead of print].
20. Malyszko J, Zbroch E, Malyszko JS, et al. Renalase, a novel regulator of blood pressure, is predicted by kidney function in renal transplant recipients. Transplant Proc. 2011, 43: 3004-3007.